OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.otsuka-us.com

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Phase 3
Completed
Conditions
First Posted Date
2002-05-09
Last Posted Date
2013-11-11
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Registration Number
NCT00036114
Locations
🇺🇸

Local Institution, Seattle, Washington, United States

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Phase 2
Completed
Conditions
First Posted Date
2002-05-09
Last Posted Date
2013-11-11
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Registration Number
NCT00036127
Locations
🇺🇸

Local Instituton, Hoffman Estates, Illinois, United States

🇺🇸

Local Institution, Milwaukee, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath